wire - news in brief


Category


Years
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Last News


Results 301 - 350 of 362.

Physics/Materials Science - Business/Economics
29.05.2017
To the limits of the feasible
First, the engineers and the physicists had to find each other. Then, however, the company Daetwyler built the undulators for the free-electron X-ray laser SwissFEL of the Paul Scherrer Institute PSI as precisely as was possible: to one-tenth of the width of a hair.
Careers/Employment - Environment/Sustainable Development
26.05.2017
Managing an eco-friendly house with Lego-like technology bricks
Managing an eco-friendly house with Lego-like technology bricks
Thanks to startup ThinkEE's modular system - which consists of technology bricks linking various connected devices - data from a host of sensors can be collected regardless of the sensors' protocols.
Environment/Sustainable Development - Business/Economics
26.05.2017
Natural disasters and climate-related risks: Switzerland appeals for closer links between disaster risk reduction, climate change and development cooperation
Natural disasters and climate-related risks: Switzerland appeals for closer links between disaster risk reduction, climate change and development cooperation Bern, 26.05.2017 - Natural disasters and climate-related risks threaten to reverse hard-won gains in development.
Medicine/Pharmacology - Life Sciences
26.05.2017
Designer Viruses Stimulate the Immune System to Fight Cancer
Swiss scientists have created artificial viruses that can be used to target cancer. These designer viruses alert the immune system and cause it to send killer cells to help fight the tumor. The results, published Communications, provide a basis for innovative cancer treatments. Most cancer cells only provoke a limited reaction from the immune system - the body's defense mechanism - and can thus grow without appreciable resistance.
Medicine/Pharmacology - Life Sciences
26.05.2017
Novartis receives FDA approval for expanded use of Zykadia in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC)
In ALK-positive metastatic NSCLC patients, Zykadia median progression-free survival (PFS) was 16.6 months, compared to 8.1 months with chemotherapy   The overall intracranial response r
Medicine/Pharmacology - Administration/Government
24.05.2017
New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF)
New data at ATS add to the body of evidence for Roche's Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF) In new post hoc analyses of phase III data, Esbriet reduced the risk of death in p
Physics/Materials Science - Chemistry
23.05.2017
Soot particles from GDI engines
Soot particles from GDI engines
Are new gasoline cars environmentally friendly? Not always, says a new study led by Empa scientists: some direct-injection gasoline engines emit just as many soot particles as unfiltered diesel cars did in the past.
Life Sciences - Medicine/Pharmacology
23.05.2017
Revealing how neurons communicate
Revealing how neurons communicate
The ETH spinoff MaxWell Biosystems AG develops microelectrode platforms for electrophysiological tests on nerve cells, opening up new possibilities for pharmaceutical research. Now, the company received CHF 130,000 in starting capital from the Venture Kick initiative MaxWell Biosystems AG's head office is hidden away in a Basel laboratory building previously used by Syngenta, just a stone's throw from ETH Zurich's Department of Biosystems Science and Engineering (D-BSSE).
Physics/Materials Science - Microtechnics/Electroengineering
23.05.2017
High voltage for tomorrow's particle accelerator
High voltage for tomorrow’s particle accelerator
On behalf of CERN, researchers at ETH Zurich have developed a high-tech device for the production of extremely precise, high voltage pulses that could be used in the next generation of particle accelerators.
Careers/Employment
23.05.2017
Swiss Labour Force Survey in 1st quarter 2017: labour supply: 1st quarter 2017: 0.6% increase in the number of employed persons. The unemployment rate based on the ILO definition settles at 5.3%
1st quarter 2017: 0.6% increase in the number of employed persons. The unemployment rate based on the ILO definition settles at 5.3% Neuchâtel, 19.05.2017 (FSO) - The number of employed persons in Switzerland rose by 0.6% between the 1st quarters of 2016 and 2017.
Medicine/Pharmacology - History/Archeology
23.05.2017
Novartis’ new analyses reinforce the potential of Ultibro Breezhaler for COPD patients historically treated with steroids
New analyses from the FLAME study suggest dual bronchodilator Ultibro Breezhaler provides similar or better efficacy versus steroid-containing therapies, regardless of blood eosinophil (a type of white blood cell)  counts   Data was published in the centenary issue of the American Thoracic Society's 'American Journal of Respiratory and Critical Care Medicine'   Together with the International Primary Care Respiratory Group, Novartis is launching
Medicine/Pharmacology - Life Sciences
23.05.2017
Discovery of a Key Regulatory Gene in Cardiac Valve Formation
Researchers from the University of Basel in Switzerland have identified a key regulator gene for the formation of cardiac valves - a process crucial to normal embryonic heart development. These results are published in the journal Cell Reports today. The heart is the first functional organ that develops in vertebrate embryos.
Medicine/Pharmacology - Life Sciences
23.05.2017
FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis
FDA approves Roche's Actemra/RoActemra (tocilizumab) for giant cell arteritis Actemra/RoActemra is the first FDA-approved treatment for adults with giant cell arteritis (GCA) FDA previously granted Priority Review and Breakthrough Therapy Designation for Actemra/RoActemra in GCA Sixth FDA approval for Actemra/RoActemra since its US launch in 2010 Roche today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra /RoActemra (tocilizumab) ) subcutaneous injection for the treatment of GCA, a chronic and severe autoimmune condition.
Astronomy - Media
22.05.2017
The race to trace TRAPPIST-1h
The race to trace TRAPPIST-1h
Media releases, information for representatives of the media Media Relations (E) After 60 hours of non-stop work, researchers at the University of Bern being part of an international team reached their hoped-for goal: They were the first to measure the orbital period for the outermost planet of the famous TRAPPIST-1 system which made headlines worldwide.
Life Sciences
22.05.2017
Digital birdhouses make studying owls easier
Digital birdhouses make studying owls easier
EPFL students have developed a system that can detect when barn owls fly into and out of their nests, without disturbing the birds.
Physics/Materials Science - Chemistry
22.05.2017
Wafer-thin Magnetic Materials Developed for Future Quantum Technologies
Wafer-thin Magnetic Materials Developed for Future Quantum Technologies
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern.
Medicine/Pharmacology - Life Sciences
19.05.2017
Novartis receives positive CHMP opinion for first-line use of Zykadia in ALK-positive advanced non-small cell lung cancer (NSCLC)
Phase III trial, first-line treatment with Zykadia resulted in improved progression-free survival (PFS) over SOC chemotherapy with maintenance, including in patients with brain metastases Zykadia is
Computer Science/Telecom - Astronomy
19.05.2017
Building trust and intelligence in a digitalised world
Building trust and intelligence in a digitalised world
ETH Meets New York to explore Blockchain technologies, machine learning, and artificial intelligence with academia and industry.
Medicine/Pharmacology
19.05.2017
Light Exposure in the Evening Improves Performance in the Final Spurt
Light Exposure in the Evening Improves Performance in the Final Spurt
Athletes often have to compete late in the evening, when they are no longer able to perform at their best. As reported in the journal Frontiers in Physiology, however, researchers from the University of Basel have shown that athletes who are exposed to blue light before competing can significantly increase their performance in the final spurt.
Medicine/Pharmacology - Life Sciences
18.05.2017
Novartis data at ASCO, ICML and EHA meetings demonstrate meaningful advancements in cancer care
Updated analyses from the Kisqali pivotal Phase III MONALEESA-2 trial in hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer to be presente
Life Sciences - Architecture
18.05.2017
15 new professors
15 new professors
At its meeting of 17 May 2017, the ETH Board appointed 15 new professors upon application of ETH Zurich President Lino Guzzella.
Physics/Materials Science - Astronomy
18.05.2017
XENON1T: the most sensitive detector on Earth
Dark matter is one of the basic constituents of the Universe, five times more abundant than ordinary matter.
Administration/Government - Careers/Employment
17.05.2017
Stable demand for SNSF funding
Stable demand for SNSF funding
In 2016, the Swiss National Science Foundation (SNSF) supported around 3200 research projects involving more than 14,000 researchers from universities, universities of applied sciences, universities
Medicine/Pharmacology
17.05.2017
Novartis Foundation and partners launch initiative to tackle hypertension and its root causes in low-income urban communities
Better Hearts Better Cities is a Novartis Foundation initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension.
Earth Sciences
16.05.2017
Reconstructing a lake's history by simple means
Reconstructing a lake’s history by simple means
Media releases, information for representatives of the media Media Relations (E) The sediments of Lake Van in Eastern Anatolia (Turkey) are a valuable climate archive.
Physics/Materials Science
16.05.2017
Persistent and curious
Persistent and curious
As Professor of Particle Physics, Felicitas Pauss played a key role in the discovery of the Higgs boson.
Physics/Materials Science - Chemistry
15.05.2017
The future's bright, the future's OLED
The future’s bright, the future’s OLED
Organic light-emitting diodes (OLEDs) will soon show our world in a new light: the days of small light sources are numbered; in future, entire walls, ceilings, façades and car exteriors will light up our lives.
Physics/Materials Science - Chemistry
12.05.2017
Hydrogen Bonds Directly Detected for the First Time
Hydrogen Bonds Directly Detected for the First Time
For the first time, scientists have succeeded in studying the strength of hydrogen bonds in a single molecule using an atomic force microscope. Researchers from the University of Basel's Swiss Nanoscience Institute network have reported the results Advances. Hydrogen is the most common element in the universe and is an integral part of almost all organic compounds.
Physics/Materials Science - Chemistry
11.05.2017
Event
11.05.2017
Social Sciences - Sport Sciences
11.05.2017
Better a ‘No’ Than No Answer at All
After experiencing social exclusion, a minimum of attention suffices to reduce individuals' negative emotions. Even rejection or unkind comments are better for well-being than being ignored by other people. This finding has important implications for the treatment of applicants during selection processes, report psychologists from the University of Basel and Purdue University in the Personality and Social Psychology Bulletin.
Medicine/Pharmacology
11.05.2017
Roche to present new data on personalised medicines and cancer immunotherapies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche to present new data on personalised medicines and cancer immunotherapies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting 20 Roche medicines are included in more than 190
Life Sciences - Medicine/Pharmacology
10.05.2017
Two major projects drive genetics research forward at Campus Biotech
Two major projects drive genetics research forward at Campus Biotech
Good news for the fields of genetic research and gene therapy: two major projects based at Campus Biotech, EPFL's outpost in Geneva, were announced simultaneously today.
Medicine/Pharmacology - Administration/Government
10.05.2017
Roche provides update on phase III study of TECENTRIQ (atezolizumab) in people with previously treated advanced bladder cancer
Roche provides update on phase III study of TECENTRIQ (atezolizumab) in people with previously treated advanced bladder cancer IMvigor211 study did not meet its primary endpoint of overall survival (
Civil Engineering/Traffic Engineering
09.05.2017
EPFL to participate in a concrete canoe race for the first time
This semester, eight civil engineering students at EPFL will take part in a slightly off-the-wall challenge: they are building a reinforced-concrete canoe that they will then race in a university regatta in Germany.
Chemistry - Physics/Materials Science
08.05.2017
Quartz powder for the battery of the future
Quartz powder for the battery of the future
The invisible becomes visible within lithium-sulphur batteries Materials researchers of the Paul Scherrer Institute PSI in Switzerland have, in collaboration with the Université Grenoble Alpes (France), developed a method that could enable a breakthrough for the lithium-sulphur battery. In theory, lithium-sulphur batteries can deliver considerably more energy than today's conventional lithium-ion batteries, but current prototypes show a distinct loss of capacity after just a few charging cycles.
Environment/Sustainable Development - Careers/Employment
08.05.2017
Immersive virtual-reality creation software for everyone
Immersive virtual-reality creation software for everyone
Imverse, an EPFL spinoff, has developed a software that lets users convert 360-degree images from 2D into 3D and both manipulate and create virtual-reality content in real time with the help of virtual-reality glasses.
Life Sciences - Environment/Sustainable Development
08.05.2017
What silver fir aDNA can tell us about Neolithic forests
What silver fir aDNA can tell us about Neolithic forests
Media releases, information for representatives of the media Media Relations (E) A new technique makes it possible to cost-effectively analyse genetic material from fossil plant and animal remains. Researchers from the Swiss Federal Institute for Forest, Snow and Landscape Research WSL and the universities of Lausanne and Bern have used this technique to examine the DNA of silver fir needles found in lake sediment in Ticino.
Environment/Sustainable Development - Careers/Employment
08.05.2017
Immersive virtual-reality software for everyone
Immersive virtual-reality software for everyone
Imverse, an EPFL spinoff, has developed software that lets users convert 360-degree images from 2D into 3D and both manipulate and create virtual-reality content in real time with the help of virtual-reality glasses.
Medicine/Pharmacology
08.05.2017
Women Perform Worse in CPR
Women Perform Worse in CPR
Does it matter whether a man or a woman carries out CPR? Researchers at the University of Basel and University Hospital Basel have shown that female resuscitation teams performed cardiopulmonary resuscitation less efficiently than their male counterparts. The study suggests that there is a need for action in the training of young female physicians.
Event
05.05.2017
Construction start for NEST unit 'dfab
Construction start for NEST unit ’dfab
On May 2, at the ground-breaking ceremony for the NEST unit ‘dfab house', the project team, consisting of the National Center of Competence in Research (NCCR) ‘Digital Fabrication', ETH Z
Computer Science/Telecom - Architecture
05.05.2017
How does trust work on the internet?
How does trust work on the internet?
A secure and reliable internet generates trust. Just how the internet creates trust is a matter for debate between ETH computer scientists and social scientists - for example, in a public session on 9 May 2017.
Medicine/Pharmacology - Life Sciences
04.05.2017
Comprehensive Atlas of Immune Cells in Renal Cancer
Comprehensive Atlas of Immune Cells in Renal Cancer
Renal cell carcinoma is one of the most frequent and deadly urogenital cancers. Even if the tumors are treated, they ultimately end in metastasis in about half of the patients. 90 percent of these patients die within five years. Thanks to new kinds of immunotherapies, the outlook of this patient group has improved, but the treatment only works for a minority of patients.
Life Sciences - Physics/Materials Science
04.05.2017
A magic hood for artificial heart pumps
A magic hood for artificial heart pumps
Ten million people in Europe alone suffer from cardiac insufficiency, or a weak heart. One day, many of them may require a heart transplant.
Physics/Materials Science - Medicine/Pharmacology
04.05.2017
Sustainable biomedical textiles for the
Sustainable biomedical textiles for the
The textile and clothing industry has a long history in Switzerland. In order to remain competitive in the international market, the industry relies on innovations.
Event
04.05.2017
Photography: An unusual and surprising picture of science
Photography: An unusual and surprising picture of science
The winning entries from the first SNSF Scientific Image Competition offer a view of science that is aesthetic, nuanced and complex.
Medicine/Pharmacology - Business/Economics
04.05.2017
Novartis exercises exclusive option agreement with Conatus for the treatment of NASH
Exclusive license for emricasan supports rapidly growing development portfolio in chronic liver diseases, including NASH   Conatus has initiated the Phase IIb ENCORE-LF clinical trial with emricasan in NASH.

 
 
Jobs listed on